InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-3.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Runge Marschall S, Director. Insider active across 1 company, notably ELI LILLY & Co. Cumulatively, 4 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €44k. History available since 15 November 2021. The latest transaction was disclosed on 20 November 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Runge Marschall S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
335 shares@ US$597.6025.9% of flowCommon StockSEC:0000059478-23-000310:0
498 shares@ US$361.1724.6% of flowCommon StockSEC:0000059478-22-000261:0
202 shares@ US$246.788.0% of flowCommon StockSEC:0000059478-22-000092:0
Canonical exit: 30 May 2022 (T+90)
677 shares@ US$258.4327.6% of flowCommon StockSEC:0000059478-21-000222:0
4 of 4 declarations
About Runge Marschall S
Marschall S. Runge is a Board Member of Eli Lilly & Co. He brings his expertise to the board, contributing to strategic decision-making for the company. His experience in the pharmaceutical sector is valuable for guiding management.
